↓ Skip to main content

Preclinical Neuropathic Pain Assessment; the Importance of Translatability and Bidirectional Research

Overview of attention for article published in Frontiers in Pharmacology, February 2021
Altmetric Badge

About this Attention Score

  • Above-average Attention Score compared to outputs of the same age (51st percentile)
  • Good Attention Score compared to outputs of the same age and source (71st percentile)

Mentioned by

twitter
3 X users

Citations

dimensions_citation
13 Dimensions

Readers on

mendeley
59 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Preclinical Neuropathic Pain Assessment; the Importance of Translatability and Bidirectional Research
Published in
Frontiers in Pharmacology, February 2021
DOI 10.3389/fphar.2020.614990
Pubmed ID
Authors

Amy S. Fisher, Michael T. Lanigan, Neil Upton, Lisa A. Lione

X Demographics

X Demographics

The data shown below were collected from the profiles of 3 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 59 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 59 100%

Demographic breakdown

Readers by professional status Count As %
Unspecified 6 10%
Professor > Associate Professor 6 10%
Student > Ph. D. Student 5 8%
Student > Bachelor 4 7%
Other 4 7%
Other 8 14%
Unknown 26 44%
Readers by discipline Count As %
Medicine and Dentistry 8 14%
Unspecified 6 10%
Neuroscience 6 10%
Pharmacology, Toxicology and Pharmaceutical Science 4 7%
Biochemistry, Genetics and Molecular Biology 2 3%
Other 7 12%
Unknown 26 44%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 3. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 21 June 2023.
All research outputs
#13,986,221
of 23,923,403 outputs
Outputs from Frontiers in Pharmacology
#4,180
of 17,767 outputs
Outputs of similar age
#244,437
of 514,570 outputs
Outputs of similar age from Frontiers in Pharmacology
#161
of 586 outputs
Altmetric has tracked 23,923,403 research outputs across all sources so far. This one is in the 40th percentile – i.e., 40% of other outputs scored the same or lower than it.
So far Altmetric has tracked 17,767 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 5.1. This one has done well, scoring higher than 75% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 514,570 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 51% of its contemporaries.
We're also able to compare this research output to 586 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 71% of its contemporaries.